Definitive diagnosis of AD is based on the histological demonstration of extracellular amyloid-Aβ42 peptide deposits (senile plaques) in the supporting tissue of the central nervous system [88] and intracellular neurofibrillary tangles of hyperphosphorylated Tau protein [89]. This evidence concerns the gene MAPT and Alzheimer disease.